Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rapid Detection of Group B Streptococcus Using a Bedside Microfluidics Device: 35-37 Week Study

NCT00331019 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT00331019
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00331019 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rapid Detection of Group B Streptococcus Using a Bedside Microfluidics Device: 35-37 Week Study
Lead sponsor
University of Michigan
Phase
Observational
Overall status
Withdrawn
Start date
July 31, 2006
Completion date
Not reported
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

group b streptococcus neonatal sepsis